Concepedia

Masamichi Mori

MM

Statistics

Publications

26

Citations

1.3K

H-Index

19

Active since

1991

Affiliations

Astellas Pharma (Japan)(Current)

Tokyo University of Agriculture

Jichi Medical University

Ono Pharmaceutical (Japan)

The University of Tokyo

Masamichi Mori is an author at Astellas Pharma (Japan) specializing in medicine, oncology, and pharmacology.

Publications per year

1991–2020

26

Publications

26

Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia

Masamichi Mori, Naoki Kaneko, Yoko Ueno et al. · Investigational New Drugs · 2017 · 254 citations · Full text

, , +16

Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade

Shinsuke Nakao, Yukinori Arai, Mamoru Tasaki et al. · Science Translational Medicine · 2020 · 188 citations

, , +17

Broad spectrum and potent antitumor activities of YM155, a novel small‐molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models

Takahito Nakahara, Aya Kita, Kentaro Yamanaka et al. · Cancer Science · 2010 · 165 citations

, , +14

Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells

Tatsuya Kawase, Taisuke Nakazawa, Tomohiro Eguchi et al. · Oncotarget · 2019 · 83 citations · Full text

, , +13

Antitumor effects of YM155, a novel survivin suppressant, against human aggressive non-Hodgkin lymphoma

Aya Kita, Takahito Nakahara, Kentaro Yamanaka et al. · Leukemia Research · 2011 · 58 citations

, , +12

1–5 of 26